ExodusPoint Capital Management LP Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)

ExodusPoint Capital Management LP lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 167.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 54,810 shares of the company’s stock after purchasing an additional 34,340 shares during the quarter. ExodusPoint Capital Management LP’s holdings in Option Care Health were worth $1,272,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Murphy & Mullick Capital Management Corp purchased a new stake in shares of Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after buying an additional 1,005 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after buying an additional 681 shares in the last quarter. Finally, Venturi Wealth Management LLC boosted its stake in shares of Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after buying an additional 4,561 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Barrington Research boosted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Price Performance

NASDAQ:OPCH opened at $33.56 on Thursday. The firm has a market cap of $5.51 billion, a price-to-earnings ratio of 28.20, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company’s 50-day moving average is $33.17 and its two-hundred day moving average is $28.58. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.